The burden of COVID-19 in French Guiana: Vaccine-averted deaths, hospitalizations and costs
Mathieu Nacher,
Nicolas Vignier,
Cyril Rousseau,
Antoine Adenis,
Maylis Douine,
Célia Basurko,
Bertrand de Toffol,
Narcisse Elenga,
Hatem Kallel,
Jean Pujot,
Magaly Zappa,
Magalie Demar,
Félix Djossou,
Pierre Couppié,
Loïc Epelboin
Affiliations
Mathieu Nacher
CIC INSERM 1424, Centre Hospitalier de Cayenne, 97300 French Guiana; Département Formation Recherche, Université de Guyane, French Guiana; Corresponding author at: CIC INSERM 1424, Centre Hospitalier de Cayenne, 97300 French Guiana.
Nicolas Vignier
CIC INSERM 1424, Centre Hospitalier de Cayenne, 97300 French Guiana
Cyril Rousseau
Santé Publique France, French Guiana
Antoine Adenis
CIC INSERM 1424, Centre Hospitalier de Cayenne, 97300 French Guiana; Département Formation Recherche, Université de Guyane, French Guiana
Maylis Douine
CIC INSERM 1424, Centre Hospitalier de Cayenne, 97300 French Guiana
Célia Basurko
CIC INSERM 1424, Centre Hospitalier de Cayenne, 97300 French Guiana
Bertrand de Toffol
Département Formation Recherche, Université de Guyane, French Guiana; Service de Neurologie, Centre Hospitalier de Cayenne, 97300 French Guiana
Narcisse Elenga
Département Formation Recherche, Université de Guyane, French Guiana; Service de Pédiatrie, Centre Hospitalier de Cayenne, 97300 French Guiana
Hatem Kallel
Service de Réanimation, Centre Hospitalier de Cayenne, 97300 French Guiana
Jean Pujot
Service de, Centre Hos Urgences, Centre Hospitalier de Cayenne, 97300 French Guiana
Magaly Zappa
Service de Radiologie, Centre Hospitalier de Cayenne, 97300 French Guiana
Magalie Demar
Laboratoire polyvalent, Centre Hospitalier de Cayenne, 97300 French Guiana; Unité Mixte de RechercheTropical Biome and Immunopathology, Université de Guyane, French Guiana
Félix Djossou
Service des Maladies Infectieuses et Tropicales, Centre Hospitalier de Cayenne, 97300 French Guiana
Pierre Couppié
Département Formation Recherche, Université de Guyane, French Guiana; Service de Dermatologie, Centre Hospitalier de Cayenne, 97300 French Guiana
Loïc Epelboin
Département Formation Recherche, Université de Guyane, French Guiana; Service de Dermatologie, Centre Hospitalier de Cayenne, 97300 French Guiana
Objectives: French Guiana, the least-vaccinated French territory, also has the lowest COVID-19 vaccination coverage in Latin America. We aimed to estimate how many deaths, hospitalizations and costs the vaccines had and could have avoided. Methods: We calculated the Number Needed to Vaccinate to prevent one death per year, 1 standard hospitalization, 1 Intensive Care Unit admission given the mean incidence numbers of the past 6 months, and divided the number of persons vaccinated to estimate how many deaths and hospitalizations had been avoided in French Guiana at that time. Results: The crude number needed to vaccinate to prevent one death per year, the crude number needed to vaccinate to prevent one hospitalization per 6 months were computed Based on our observed incidence and ICU admission rate, the crude number needed to vaccinate to prevent one ICU admission per 6 months.After 6 months with an incidence exceeding 400 per million inhabitants, and 148 observed deaths, we estimate that vaccination avoided 46 deaths (IC95%=43.5–48.7). If the number of vaccinated persons had reached the same proportion as mainland France, 141 deaths per year could have been prevented (IC95%=131.9–147.6).With 2085 hospitalization and 370 ICU admissions during the same period, we estimate that the current albeit low vaccination rate avoided 300 hospital (IC95%=280–313) and 77 (IC95%=72–81) ICU admissions. With the same vaccination rates as mainland France, we estimate that 900 hospitalizations and 231 ICU admissions would have been avoided.Similarly, there would have been 139 ICU admission (instead of 370). Conclusions: In sparsely populated French Guiana these numbers are quite substantial and framing the vaccine benefits and wasted opportunities using such concrete numbers may help convincing undecided persons to get vaccinated.